Skip to results
Modify your search
NARROW
1-6 of 6
Authors: Rita Cascão
Sort by
Journal Article
UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease Open Access
Eunice Paisana and others
Neuro-Oncology Advances, Volume 5, Issue 1, January-December 2023, vdad048, https://doi.org/10.1093/noajnl/vdad048
Published: 28 April 2023
Journal Article
BSCI-04 TARGETING THE PI3K-MTOR PATHWAY TO TREAT UBE2C-DRIVEN BRAIN METASTASES Open Access
Eunice Paisana and others
Neuro-Oncology Advances, Volume 4, Issue Supplement_1, August 2022, Pages i1–i2, https://doi.org/10.1093/noajnl/vdac078.004
Published: 05 August 2022
Journal Article
Intratumoral heterogeneity of MYC drives medulloblastoma metastasis and angiogenesis Free
Nan Qin and others
Neuro-Oncology, Volume 24, Issue 9, September 2022, Pages 1509–1523, https://doi.org/10.1093/neuonc/noac068
Published: 21 March 2022
Journal Article
LMD-12. Ubiquitin Conjugating Enzymes promote leptomeningeal dissemination and decrease survival in patients with brain metastatic disease Open Access
Eunice Paisana and others
Neuro-Oncology Advances, Volume 3, Issue Supplement_3, August 2021, Page iii10, https://doi.org/10.1093/noajnl/vdab071.037
Published: 09 August 2021
Journal Article
EPEN-33. PHARMACOGENOMICS REVEALS SYNERGISTIC INHIBITION OF ERBB2 AND PI3K SIGNALING AS A THERAPEUTIC STRATEGY FOR EPENDYMOMA Open Access
David Pauck and others
Neuro-Oncology, Volume 22, Issue Supplement_3, December 2020, Page iii314, https://doi.org/10.1093/neuonc/noaa222.168
Published: 04 December 2020
Journal Article
BIOL-02. CELLULAR HETEROGENEITY CONTRIBUTES TO THE AGGRESSIVE BEHAVIOR OF MYC-DRIVEN MEDULLOBLASTOMA Free
Nan Qin and others
Neuro-Oncology, Volume 21, Issue Supplement_2, April 2019, Page ii66, https://doi.org/10.1093/neuonc/noz036.015
Published: 23 April 2019